Minocycline Slows Disease Progression in a Mouse Model of Amyotrophic Lateral Sclerosis
Authors:
- Minh Dang NguyenMNMinh Dang Nguyen
- Jean-Pierre JulienJJJean-Pierre Julien
- 1 August 2002
- journal article
- research article
- Published by Elsevier in Neurobiology of Disease
- Vol. 10 (3) , 268-278
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation, Tissue Damage, and Neurological DysfunctionNeurosurgery, 2001
- Amyotrophic Lateral SclerosisCell, 2001
- From Charcot to SOD1Neuron, 1999
- Beneficial Effects of Lysine Acetylsalicylate, a Soluble Salt of Aspirin, on Motor Performance in a Transgenic Model of Amyotrophic Lateral SclerosisExperimental Neurology, 1999
- Epidemiology of mutations in superoxide dismutase in amyotrophic lateal sclerosisAnnals of Neurology, 1997
- Safety of long-term high-dose minocycline in the treatment of acneBritish Journal of Dermatology, 1996
- Aging, energy, and oxidative stress in neurodegenerative diseasesAnnals of Neurology, 1995
- An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondriaNeuron, 1995
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993
- Suppression of human neutrophil functions by tetracyclinesJournal of Periodontal Research, 1991